Tag: Luk H. Vandenberghe
Providence retinal disease treatment firm publicly launches
PROVIDENCE – Lyora Therapeutics, a Providence-based biotech company specializing in the treatment of hereditary retinal diseases, has officially launched publicly after operating in stealth for the past year.
Lyora’s portfolio...









